TMEM2 抗体 (Middle Region)
(1 reference)Quick Overview for TMEM2 抗体 (Middle Region) (ABIN2775385)
抗原
See all TMEM2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- Middle Region
-
序列
- MLTGLCQGCG TRQVVFTSDP HKSYLPVQFQ SPDKAETQRG DPSVISVNGT
-
预测反应
- Cow: 86%, Dog: 93%, Guinea Pig: 93%, Horse: 93%, Human: 100%, Mouse: 93%, Pig: 100%, Rabbit: 100%, Rat: 100%
-
产品特性
- This is a rabbit polyclonal antibody against TMEM2. It was validated on Western Blot using a cell lysate as a positive control.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the middle region of human TMEM2
-
-
anti-Transmembrane Protein 2 (TMEM2) (AA 734-866) antibody
TMEM2 适用: 人 ELISA, IF, IHC 宿主: 兔 Polyclonal unconjugated
anti-Transmembrane Protein 2 (TMEM2) (N-Term) antibodyTMEM2 适用: 人, 小鼠, 大鼠, Cow, 兔, 犬, 马, Bat WB 宿主: 兔 Polyclonal unconjugated
anti-Transmembrane Protein 2 (TMEM2) (AA 1187-1236) antibodyTMEM2 适用: 人, Cow, 兔, Bat, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Transmembrane Protein 2 (TMEM2) (N-Term) antibodyTMEM2 适用: 人, 小鼠, 大鼠, Cow, 兔, 犬, 马, Pig WB 宿主: 兔 Polyclonal unconjugated
anti-Transmembrane Protein 2 (TMEM2) antibodyTMEM2 适用: 小鼠 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
-
说明
-
Antigen size: 1383 AA
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway." in: Cell death & disease, Vol. 7, Issue 6, pp. e2239, (2016) (PubMed).
-
: "TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway." in: Cell death & disease, Vol. 7, Issue 6, pp. e2239, (2016) (PubMed).
-
-
